Tourmaline Bio Balance Sheet Health
Financial Health criteria checks 6/6
Tourmaline Bio has a total shareholder equity of $205.0M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $210.3M and $5.3M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$202.95m |
| Equity | US$205.04m |
| Total liabilities | US$5.25m |
| Total assets | US$210.30m |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: TRML's short term assets ($208.9M) exceed its short term liabilities ($5.0M).
Long Term Liabilities: TRML's short term assets ($208.9M) exceed its long term liabilities ($251.0K).
Debt to Equity History and Analysis
Debt Level: TRML is debt free.
Reducing Debt: TRML had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: TRML has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: TRML has sufficient cash runway for 3 years if free cash flow continues to reduce at historical rates of 85.6% each year.